×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Cardio-facio-cutaneous syndrome
0.570
Biomarker
CLINGEN
×
Entrez Id:
6016
Gene Symbol:
RIT1
RIT1
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
5500
Gene Symbol:
PPP1CB
PPP1CB
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
6237
Gene Symbol:
RRAS
RRAS
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
144568
Gene Symbol:
A2ML1
A2ML1
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
5921
Gene Symbol:
RASA1
RASA1
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
8216
Gene Symbol:
LZTR1
LZTR1
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
5922
Gene Symbol:
RASA2
RASA2
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
6655
Gene Symbol:
SOS2
SOS2
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
22808
Gene Symbol:
MRAS
MRAS
Cardio-facio-cutaneous syndrome
0.300
Biomarker
CLINGEN
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Cardio-facio-cutaneous syndrome
1.000
Biomarker
CLINGEN
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.
16439621
2006
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
Cardio-facio-cutaneous syndrome
1.000
Biomarker
CLINGEN
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.
16439621
2006
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Cardio-facio-cutaneous syndrome
1.000
Biomarker
CLINGEN
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome .
16474404
2006
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Cardio-facio-cutaneous syndrome
0.800
Biomarker
CLINGEN
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome .
16474404
2006
×
Entrez Id:
5605
Gene Symbol:
MAP2K2
MAP2K2
Cardio-facio-cutaneous syndrome
0.800
Biomarker
CLINGEN
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.
16439621
2006
×
Entrez Id:
5605
Gene Symbol:
MAP2K2
MAP2K2
Cardio-facio-cutaneous syndrome
0.800
Biomarker
CLINGEN
Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.
17366577
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Cardio-facio-cutaneous syndrome
0.800
Biomarker
CLINGEN
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
17704260
2007
×
Entrez Id:
5605
Gene Symbol:
MAP2K2
MAP2K2
Cardio-facio-cutaneous syndrome
0.800
Biomarker
CLINGEN
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
17704260
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Cardio-facio-cutaneous syndrome
0.800
Biomarker
CLINGEN
We further defined the phenotypic spectrum associated with KRAS missense mutations and provided the first evidence of clinical differences in patients with KRAS mutations compared with Noonan syndrome affected individuals with heterozygous PTPN11 mutations and CFC patients carrying a BRAF, MEK1 or MEK1 alteration, respectively.
17056636
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Cardio-facio-cutaneous syndrome
0.800
Biomarker
CLINGEN
De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.
17601930
2007
×
Entrez Id:
6654
Gene Symbol:
SOS1
SOS1
Cardio-facio-cutaneous syndrome
0.330
Biomarker
CLINGEN
Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
17143285
2007
×
Entrez Id:
6654
Gene Symbol:
SOS1
SOS1
Cardio-facio-cutaneous syndrome
0.330
Biomarker
CLINGEN
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.
17143282
2007
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
Cardio-facio-cutaneous syndrome
1.000
Biomarker
CLINGEN
Approximately 25% of individuals with CFC have mutations in either MEK1 or MEK2 that lead to increased MEK kinase activity as judged by increased phosphorylation of its downstream effector ERK.
18413255
2008
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
Cardio-facio-cutaneous syndrome
1.000
Biomarker
CLINGEN
Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.
17981815
2008
×
Entrez Id:
5605
Gene Symbol:
MAP2K2
MAP2K2
Cardio-facio-cutaneous syndrome
0.800
Biomarker
CLINGEN
Approximately 25% of individuals with CFC have mutations in either MEK1 or MEK2 that lead to increased MEK kinase activity as judged by increased phosphorylation of its downstream effector ERK.
18413255
2008